← Back to all trials
Not Yet Recruiting
NCT07756346
A Study to Evaluate the Efficacy of Botulinum Toxin in Patients With Hidradenitis Suppurativa
Conditions: Hidradenitis Suppurativa (HS)
Sex: All
Ages: 13 Years – 75 Years
Healthy volunteers: No
Phase: PHASE2
Enrollment: 40
Sponsor: University of Massachusetts, Worcester
Location: UMass Chan Medical School Worcester Massachusetts
Summary
This study will build on data from mice and humans implicating TRPV1 nociceptors in the pathogenesis of the type-17 chronic inflammatory skin disease hidradenitis suppurativa (HS). In this study, the investigators will extend data from a 12-week pilot study to rigorously test the hypothesis that botulinum toxin (BoNT) therapy reduces disease severity and relieves HS pain symptoms..
Eligibility Criteria
Inclusion Criteria:
1\) age \>13 and \
Source: ClinicalTrials.gov (NCT07756346). StuddyBuddy aggregates publicly available trial information.
